Pathogen genomic surveillance in health care: emerging ethical dilemmas in outbreak detection and patient notification.

Authors

Alexander J Sundermann, Waleed Javaid, Lisa Parker

Published in

Infection control and hospital epidemiology. Pages 1-6. Aug 04, 2026. Epub Aug 04, 2026.

Abstract

Genomic surveillance detects healthcare-associated outbreaks that are often missed by traditional methods, offering substantial benefits for infection prevention. However, its use introduces complex ethical questions regarding patient notification and disparities in outbreak detection between institutions with and without genomic capabilities. In this commentary, we apply the Centers for Disease Control and Prevention's 2020 ethical considerations regarding patient notification and the Ethical Infection Prevention and Control (EIPAC) framework to two hypothetical scenarios involving genomic surveillance programs. We identify ethical justifications for patient notification when both genomic and epidemiologic evidence suggest transmission, as well as considerations militating for and against notification when epidemiologic evidence supporting genomic findings is absent. Our analysis, informed by qualitative research reporting the types of harm experienced by patients across detected and undetected outbreaks, includes a matrix illustrating physical, psychological, and ethical harms associated with different detection and disclosure conditions. We also discuss ethical concerns arising from institutional disparities in genomic capability such that patients in hospitals without genomic surveillance may suffer preventable harm and remain uninformed due to lack of detection. We recognize that hospitals adopting genomic surveillance face new ethical duties to disclose transmission events, while those that do not engage in such surveillance risk perpetuating inequities in patient safety and transparency. We argue that national guidance is needed to ensure consistency in notification and promote ethical use of genomics. Coordinated frameworks from professional societies should define genetic thresholds warranting disclosure, address disparities in pathogen genomic detection methods, and uphold patient trust in the genomic era.

PMID:
42549562
Bibliographic data and abstract were imported from PubMed on 04 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.